HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J P Kleim Selected Research

GW420867X

4/2000Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J P Kleim Research Topics

Disease

1HIV Infections (HIV Infection)
06/2001
1Infections
04/2000

Drug/Important Bio-Agent (IBA)

1HIV Reverse TranscriptaseIBA
06/2001
1GW420867XIBA
04/2000
1Antiviral Agents (Antivirals)IBA
04/2000
1efavirenz (Sustiva)FDA Link
04/2000
1Lamivudine (Epivir)FDA Link
04/2000
1abacavir (Ziagen)FDA Link
04/2000